1. Home
  2. AIRE vs CLNN Comparison

AIRE vs CLNN Comparison

Compare AIRE & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo reAlpha Tech Corp.

AIRE

reAlpha Tech Corp.

N/A

Current Price

$0.28

Market Cap

56.9M

Sector

N/A

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

N/A

Current Price

$5.35

Market Cap

48.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AIRE
CLNN
Founded
2021
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
56.9M
48.4M
IPO Year
2023
N/A

Fundamental Metrics

Financial Performance
Metric
AIRE
CLNN
Price
$0.28
$5.35
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$2.00
$32.67
AVG Volume (30 Days)
1.3M
60.3K
Earning Date
05-18-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$948,420.00
N/A
Revenue This Year
$470.21
N/A
Revenue Next Year
$143.58
$82.05
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.14
$2.28
52 Week High
$1.55
$13.50

Technical Indicators

Market Signals
Indicator
AIRE
CLNN
Relative Strength Index (RSI) 31.57 56.65
Support Level $0.14 $3.54
Resistance Level $0.35 $5.71
Average True Range (ATR) 0.02 0.47
MACD 0.00 0.11
Stochastic Oscillator 6.80 85.13

Price Performance

Historical Comparison
AIRE
CLNN

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: